Prices of 651 essential medicines down by 7 percent MD Bureau3 April 2023 11:11 AM GMTConsumers will benefit from this decline in prices despite a 12.12 per cent annual hike in prices of drugs based on WPI, NPPA said.
Domestic pharma industry revenues expected to grow 6-8 percent next fiscal: Rating agency ICRA Ruchika Sharma18 March 2023 4:30 AM GMTIn terms of emerging trends in the industry, e-pharmacies have gained significant traction in recent years and now account for 10-15 percent of the...
India's domestic pharma market to reach USD 130 billion by 2030: Economic Survey Ruchika Sharma1 Feb 2023 6:00 AM GMTIn terms of making drugs affordable to the common people, the survey said checks on pharmaceutical prices have been kept through the principles for...
Coronary stents added to NLEM 2022 Dr. Nandita Mohan21 Nov 2022 12:11 PM GMTIn a move to ensure affordable medical devices in the country, the Union health ministry has announced the inclusion of coronary stents in the...
Health Bulletin 21/November/2022 Dr. Nandita Mohan21 Nov 2022 11:53 AM GMTHere are the top health news for the day:TN Govt Doctors Association threaten stir over negligence case against medicosRaising their voice against the...
Coronary stents now included in NLEM 2022 Ruchika Sharma21 Nov 2022 11:15 AM GMTThe National Pharmaceutical Pricing Authority (NPPA) will now fix the price of coronary stents.
Removed NLEM drugs cause cancer is false statement: Experts Ruchika Sharma23 Oct 2022 9:31 AM GMTThe 26 drugs that have been dropped from the list include Ranitidine, Sucralfate, white petrolatum, Atenolol, and Methyldopa.
Union Health Ministry releases NLEM 2022, 34 drugs added, 26 removed Farhat Nasim13 Sep 2022 12:26 PM GMTNew Delhi: The Union Health Ministry on Tuesday released the National List of Essential Medicines (NLEM) 2022 . The new list comprises of 384 drugs...
Govt adds 39 drugs in NLEM, NPPA to do final price cap Medical Dialogues Team4 Sep 2021 11:51 AM GMTNew Delhi: The Union government has revised the National List of Essential Medicines (NLEM) by adding 39 new drugs under the list for proposed price...
NPPA to issue show-cause notice to Intas, Mankind Pharma for selling diabetes drug sans approval MD Bureau2 Jan 2021 11:26 AM GMTNew Delhi: Coming down on Mankind Pharma and Intas Pharmaceuticals, the National Pharmaceutical Pricing Authority (NPPA) has decided to issue...
How to discontinue with scheduled formulations: NPPA issues draft guidelines for pharma Farhat Nasim3 Jun 2020 11:38 AM GMTNew Delhi: The apex drug pricing regulator, National Pharmaceutical Pricing Authority (NPPA) has formulated Draft Guidelines formulated for dealing...
